Natural Purple foods offer Numerous Health Benefits

Authors

  • Jyoti Srivastava Advance Institute of Biotech & Paramedical Sciences, Naramau , Kanpur
  • Padma S Vankar Facility for Ecological and Analytical Testing, Indian Institute of Technology, Kanpur 208016 India.

Keywords:

Pharmacopedia, Bioactive compound, Ficus carica, Brassica oleracea, Folin-ciocalteu, Olea europaea, Antioxidant activity, DPPH, FRAP

Abstract

Fruit and vegetable have been the source of many medicines in the pharmacopoeia. So much so that an
industry has arisen selling plant extracts as health foods. The present study was carried out to evaluate
the bioactive compounds in red and purple fruit and vegetables (Rubus fruticosus, VitisHYPERLINK “http://
en.wikipedia.org/wiki/Vitis_labrusca” HYPERLINK “http://en.wikipedia.org/wiki/Vitis_labrusca”labrusca,
Ficus carica, Olea europaea, Punica granatum, DaucusHYPERLINK “http://en.wikipedia.org/wiki/Daucus_
carota” HYPERLINK “http://en.wikipedia.org/wiki/Daucus_carota”carota, Prunus Americana, Beta vulgaris,
Brassica oleracea). Extraction of nine different foods in methanol yielded highest extraction in Ficus carica
(fig) 44.95 %. This research studies showed high content of total Phenol in Brassica oleracea (purple
cabbage) 122.355 mg /g GAE determined by the Folin-Ciocalteu reagent and total flavonoid content in
Olea europaea (black olive) 60.097 mg /g QE. The antioxidant activities determined by the DPPH and FRAP
methods, very high values of antioxidant activity were found in all intensely colored vegetables especially
in red cabbage 84.96 % and 37.085 respectively. Values were very low in black olive 28.03% and 7.916.

References

1. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 1993; 90: 7915-7922.
2. Doll, R. An overview of the epidemiological evidence linking diet and cancer. Proc. Nutr. Soc. 1990; 49: 119-
131.
3. Dragsted LO, Strube J, Larsen JC. Cancer protective factors in fruits and vegetables: biochemical and biological background. Pharmacol. Toxicol. 1993; 72: S116-S135.
4. Acheson RM, Williams DRR. Does consumption of fruit and vegetables protect against stroke? The Lancet.
1983; 321(8335): 1191-1193.
5. Armstrong D. Ed. In Free Radicals and Antioxidant Protocols. Methods in Molecular Biology. Humana Press: Totowa, NJ. 1988; 108: vii.
6. Burr ML, Sweetnam PM. Vegetarianism, dietary fiber, and mortality. American Journal of Clinical Nutrition.
1982; 36: 873-877.
7. Verlangieri AJ, Kapeghian JC, El-Dean S, Bush M. Fruit and vegetable consumption and cardiovascular
mortality. Medical Hypothesis. 1985; 16: 7-15.
8. Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ. A prospective study of nutritional factors and hypertension among US men. Circulation. 1992; 86: 1475-1484.
9. Sacks FM, Kass EH. Low blood pressure in vegetarians: effects of specific foods and nutrients. Am J Clin Nutr.
1998; 48(3): 795-800.
10. Gey KF, Stähelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher
mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin. Invest. 1993; 71: 3–6.
11. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris
and plasma concentrations of vitamins A, C, and E and carotene. Lancet. 1991; 337: 1-5.
12. Lansky E, Shubert S, Neeman I. Pharmacological and therapeutical properties of pomegranate. In Proceedings 1st International Symposium on Pomegranate, Eds; CIHEAM, Orihuela, Spain. 1988.
Pr-07.
13. Kashiwada Y, Nonaka G, Nishioka I, Lee KJ, Bori I, Fukushima Y, Bastow KF, Lee KH. Tannins as potent inhibitors of DNA topoisomerase II in vitro. Journal of Pharmaceutical Sciences. 1993; 82: 487–492.
14. Su JD, Osawa T, Kawakishi S, Namili M. Tannin antioxidants from Osbeckia chinesis. Phytochemistry.
1988; 27: 1315-1319.
15. Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of
pomegranate seed oil and fermented juice flavonoids. J. Ethnopharmacol. 1999; 66: 11-17.
16. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents.
Am. J. Enol. Vitic. 1965; 16: 144-158.
17. Chang C, Yang M, Wen H, Chern J. Estimation of total flavonoid content in propolis by two complementary
colorimetric methods. J.Food Drug Analaysis. 2002; 10: 178-182.
18. Fuleki T, Francis FJ. Determination of total anthocyanin and degradation index for cranberry juice. Food Science. 1968; 33(1): 78–83.
19. Lee J, Durst RW, Wroistad RL. Determination of total monomeric anthocyanin pigment content of fruit juices, beverages, natural colorants, and wines by the pH differential method: collaborative study. J. AOAC
Intl. 2005; 88: 1269-1278.
20. Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958; 26: 1199-2000.
21. Ka¨hko¨nen MP, Hopia AI, Vuorela HJ, Rauha JP, Pihlaja K, Kujala TS, Heinonen M. Antioxidant activity of plant
extracts containing phenolic compounds. Journal of Agricultural & Food Chemistry. 1999; 47(10): 3954–
3962.
22. Yeldirim A, Oktay M, Bilalolu V. The antioxidant activities of the leaves of Cydonia vulgaris. Turk. J. Med. Sci.
2001; 31: 23?27.

Downloads

Published

2018-10-26

How to Cite

Srivastava, J., & Vankar, P. S. (2018). Natural Purple foods offer Numerous Health Benefits. Journal of Drug Discovery and Development ( ISSN:2581-6861), 1(1), 30-36. Retrieved from https://medicaljournalshouse.com/index.php/JDrug-Discovery-Development/article/view/51

Issue

Vol. 1 No. 1 (2017): Journal of Drug Discovery and Development

Section

Articles

License

We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-

Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________

Important

(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.

(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.